Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T‐cell lymphoblastic leukemia

A case of an early‐relapsed high‐risk T‐ALL with high BCL‐2 expression on leukemic blasts was successfully treated with decitabine and venetoclax, achieving a CR. We suggest decitabine and venetoclax should be synergistic in BCL2‐positive ALL.

Detalles Bibliográficos
Autores principales: Zappone, Elisabetta, Cencini, Emanuele, Defina, Marzia, Sicuranza, Anna, Gozzetti, Alessandro, Ciofini, Sara, Raspadori, Donatella, Mecacci, Bianca, Bocchia, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562845/
https://www.ncbi.nlm.nih.gov/pubmed/33088538
http://dx.doi.org/10.1002/ccr3.3041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562845/
https://www.ncbi.nlm.nih.gov/pubmed/33088538
http://dx.doi.org/10.1002/ccr3.3041

Ejemplares similares